IP Verse

Green Cross competitive analysis

Latest oppositions filed by Green Cross

Explore patent oppositions filed by Green Cross against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026

Patent Number	Title	Applicant	Opposition Date
EP3626258	Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase	SHIRE HUMAN GENETIC THERAPIES	May 3, 2022
EP3103469	Cns Delivery Of Therapeutic Agents	SHIRE HUMAN GENETIC THERAPIES	Sep 9, 2021

Latest patents of Green Cross opposed by its competitors

Explore Green Cross's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026

Patent Number	Publication Date	Title	Total Oppositions
EP2723369	May 10, 2023	Composition And Formulation Comprising Recombinant Human Iduronate-2-Sulfatase And Preparation Method Thereof	1

Latest PTAB cases involving Green Cross

Discover the latest PTAB cases involving Green Cross, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 18, 2026

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Green Cross
IPR2016-00258	Nov 25, 2015	GREEN CROSS	SHIRE HUMAN GENETIC THERAPIES	Final Written Decision
IPR2016-00258	Nov 25, 2015	GREEN CROSS CORPORATION	SHIRE HUMAN GENETIC THERAPIES	Final Written Decision

Peer Comparison New

IP litigation analysis comparing Green Cross with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
GREEN CROSS	-	-	1	-
SHIRE HUMAN GENETIC THERAPIES	3	14	-	1